Literature DB >> 24094322

Mesenchymal stromal cells: sensors and switchers of inflammation.

Maria Ester Bernardo1, Willem E Fibbe.   

Abstract

In addition to their stem/progenitor properties, mesenchymal stromal cells (MSCs) possess broad immunoregulatory properties that are being investigated for potential clinical application in treating immune-based disorders. An informed view of the scope of this clinical potential will require a clear understanding of the dynamic interplay between MSCs and the innate and adaptive immune systems. In this Review, we outline current insights into the ways in which MSCs sense and control inflammation, highlighting the central role of macrophage polarization. We also draw attention to functional differences seen between vivo and in vitro contexts and between species. Finally, we discuss progress toward clinical application of MSCs, focusing on GvHD as a case study.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24094322     DOI: 10.1016/j.stem.2013.09.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  517 in total

Review 1.  Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.

Authors:  Nayoun Kim; Seok-Goo Cho
Journal:  Int J Hematol       Date:  2015-12-11       Impact factor: 2.490

2.  A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

Authors:  J Stolk; W Broekman; T Mauad; J J Zwaginga; H Roelofs; W E Fibbe; J Oostendorp; I Bajema; M I M Versteegh; C Taube; P S Hiemstra
Journal:  QJM       Date:  2016-01-27

Review 3.  Targeting Stem Cells in Chronic Inflammatory Diseases.

Authors:  Mari van de Vyver; Carine Smith; Yigael S L Powrie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

5.  Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors.

Authors:  Dawei Liu; Xiaoxing Kou; Chider Chen; Shiyu Liu; Yao Liu; Wenjing Yu; Tingting Yu; Ruili Yang; Runci Wang; Yanheng Zhou; Songtao Shi
Journal:  Cell Res       Date:  2018-07-20       Impact factor: 25.617

Review 6.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors.

Authors:  Raul German Spallanzani; David Zemmour; Tianli Xiao; Teshika Jayewickreme; Chaoran Li; Paul J Bryce; Christophe Benoist; Diane Mathis
Journal:  Sci Immunol       Date:  2019-05-03

Review 8.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

9.  Anti-inflammatory Effects of Oct4/Sox2-overexpressing Human Adipose Tissue-derived Mesenchymal Stem Cells.

Authors:  Qiang Li; Sei-Myoung Han; Woo-Jin Song; Sang-Chul Park; Min-Ok Ryu; Hwa-Young Youn
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

10.  The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing.

Authors:  Xiaoxing Kou; Xingtian Xu; Chider Chen; Maria Laura Sanmillan; Tao Cai; Yanheng Zhou; Claudio Giraudo; Anh Le; Songtao Shi
Journal:  Sci Transl Med       Date:  2018-03-14       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.